Brief: Renovorx Announces Presentation At Symposium On Clinical Interventional Oncology (CIO) Highlighting Its Innovative Therapy Platform For Targeted Treatment Of Pancreatic Cancer
28/09/2022 14:01
Sept 28 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES PRESENTATION AT SYMPOSIUM ON CLINICAL
INTERVENTIONAL ONCOLOGY (CIO) HIGHLIGHTING ITS INNOVATIVE
THERAPY PLATFORM FOR TARGETED TREATMENT OF PANCREATIC CANCER
Source text for Eikon: ID:nBw6kZMw6a
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies